BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32080953)

  • 1. Frequent homozygous deletion of Cdkn2a/2b in tremolite-induced malignant mesothelioma in rats.
    Okazaki Y; Misawa N; Akatsuka S; Kohyama N; Sekido Y; Takahashi T; Toyokuni S
    Cancer Sci; 2020 Apr; 111(4):1180-1192. PubMed ID: 32080953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibers in lung tissues of mesothelioma cases among miners and millers of the township of Asbestos, Quebec.
    Dufresne A; Harrigan M; Massé S; Bégin R
    Am J Ind Med; 1995 Apr; 27(4):581-92. PubMed ID: 7793429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
    Gamble JF; Gibbs GW
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat model demonstrates a high risk of tremolite but a low risk of anthophyllite for mesothelial carcinogenesis.
    Aierken D; Okazaki Y; Chew SH; Sakai A; Wang Y; Nagai H; Misawa N; Kohyama N; Toyokuni S
    Nagoya J Med Sci; 2014 Feb; 76(1-2):149-60. PubMed ID: 25130001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chrysotile, tremolite, and malignant mesothelioma in man.
    Churg A
    Chest; 1988 Mar; 93(3):621-8. PubMed ID: 2830081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asbestos fibers contributing to the induction of human malignant mesothelioma.
    Suzuki Y; Yuen SR
    Ann N Y Acad Sci; 2002 Dec; 982():160-76. PubMed ID: 12562635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An updated evaluation of reported no-observed adverse effect levels for chrysotile, amosite, and crocidolite asbestos for lung cancer and mesothelioma.
    Beckett EM; Abelmann A; Roberts B; Lewis RC; Cheatham D; Miller EW; Hall E; Pierce JS
    Crit Rev Toxicol; 2023 Nov; 53(10):611-657. PubMed ID: 38126124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology examination following short-term exposure.
    Bernstein DM; Chevalier J; Smith P
    Inhal Toxicol; 2005 Aug; 17(9):427-49. PubMed ID: 16020039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma.
    Hu Q; Akatsuka S; Yamashita Y; Ohara H; Nagai H; Okazaki Y; Takahashi T; Toyokuni S
    Lab Invest; 2010 Mar; 90(3):360-73. PubMed ID: 20065947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung asbestos content in chrysotile workers with mesothelioma.
    Churg A; Wiggs B; Depaoli L; Kampe B; Stevens B
    Am Rev Respir Dis; 1984 Dec; 130(6):1042-5. PubMed ID: 6095707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.
    Garabrant DH; Pastula ST
    Toxicol Appl Pharmacol; 2018 Dec; 361():127-136. PubMed ID: 30077661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Calidria chrysotile asbestos to pure tremolite: inhalation biopersistence and histopathology following short-term exposure.
    Bernstein DM; Chevalier J; Smith P
    Inhal Toxicol; 2003 Dec; 15(14):1387-419. PubMed ID: 14648356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asbestos in the lungs of persons exposed in the USA.
    Langer AM; Nolan RP
    Monaldi Arch Chest Dis; 1998 Apr; 53(2):168-80. PubMed ID: 9689804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload signature in chrysotile-induced malignant mesothelioma.
    Jiang L; Akatsuka S; Nagai H; Chew SH; Ohara H; Okazaki Y; Yamashita Y; Yoshikawa Y; Yasui H; Ikuta K; Sasaki K; Kohgo Y; Hirano S; Shinohara Y; Kohyama N; Takahashi T; Toyokuni S
    J Pathol; 2012 Nov; 228(3):366-77. PubMed ID: 22864872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tremolite asbestos exposures associated with the use of commercial products.
    Finley BL; Pierce JS; Phelka AD; Adams RE; Paustenbach DJ; Thuett KA; Barlow CA
    Crit Rev Toxicol; 2012 Feb; 42(2):119-46. PubMed ID: 22141364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tremolite and mesothelioma.
    Roggli VL; Vollmer RT; Butnor KJ; Sporn TA
    Ann Occup Hyg; 2002 Jul; 46(5):447-53. PubMed ID: 12176759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asbestos-related disease associated with exposure to asbestiform tremolite.
    Srebro SH; Roggli VL
    Am J Ind Med; 1994 Dec; 26(6):809-19. PubMed ID: 7892832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant mesothelioma caused by childhood exposure to long-fiber low aspect ratio tremolite.
    Magee F; Wright JL; Chan N; Lawson L; Churg A
    Am J Ind Med; 1986; 9(6):529-33. PubMed ID: 3017103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesothelioma and asbestos fiber type. Evidence from lung tissue analyses.
    McDonald JC; Armstrong B; Case B; Doell D; McCaughey WT; McDonald AD; Sébastien P
    Cancer; 1989 Apr; 63(8):1544-7. PubMed ID: 2924262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.